Biomedical Enterprises, Inc. (BME), a "C" corporation registered in Maryland, is focused on the validation and commercialization of an apparatus to treat systemic infections for which there is no known treatment available with heat and ultraviolet light (UVL). This product fulfills an unmet demand and the founder's knowledge of dialysis and experience treating patients with blood infections in intensive care units allowed identifying this solution. Previously, BME has validated an innovative design of a dialysis needle with $1.5 million funds awarded by the National Institute of Health (NIH). The performed research studies demonstrated that the new needle, the BME needle, causes less damage to white cells, a smaller release of pro-inflammatory cytokines, and less inflammation. A discovery of great clinical significance. The needle received the NIH's support through a commercialization assistance program.
View Top Employees from Biomedical Enterprises IncWebsite | http://www.bmedevices.net |
Revenue | $400000 |
Employees | 6 (2 on RocketReach) |
Founded | 1998 |
Address | 5241 Crown Street, Bethesda, Maryland 20816, US |
Phone | (301) 469-5112 |
Technologies | |
Industry | Medical Equipment Manufacturing, Hospitals & Clinics, Medical Devices For Hemodialysis, Healthcare |
SIC | SIC Code 80 Companies, SIC Code 809 Companies |
NAICS | NAICS Code 621492 Companies, NAICS Code 62149 Companies, NAICS Code 62 Companies, NAICS Code 6214 Companies, NAICS Code 621 Companies |
Looking for a particular Biomedical Enterprises Inc employee's phone or email?
The Biomedical Enterprises Inc annual revenue was $400000 in 2024.
Alfredo Zarate is the CEO of Biomedical Enterprises Inc.
2 people are employed at Biomedical Enterprises Inc.
Biomedical Enterprises Inc is based in Bethesda, Maryland.
The NAICS codes for Biomedical Enterprises Inc are [621492, 62149, 62, 6214, 621].
The SIC codes for Biomedical Enterprises Inc are [80, 809].